A first-in-human clinical trial of an immune rejuvenation therapy designed to restore the function of worn-out T cells is expected to begin later this year, building...
Vipoglanstat has reached the halfway point for patient recruitment in a phase 2 endometriosis trial. Gesynta Pharma said 50 per cent of the target of 190...
By Wolfgang Hackl, CEO, OncoGenomX Inc., Allschwil, Switzerland As the FemTech World Awards 2026 winners are revealed, it is a privilege to reflect on the Research...
WEC chair Sarah Owen has criticised delays over a ban on high harm cosmetic procedures, including liquid BBLs. The Women and Equalities Committee has published a...
Women who do not use menopausal hormone therapy have a greater risk of developing osteopenia or osteoporosis, conditions that weaken bones and can lead to fractures,...
Light exercise and less sitting may reduce pregnant women’s risk of serious blood pressure complications, according to a new study. Researchers have proposed a daily activity...
We are excited to reveal the winners of the third annual Femtech World Awards. The winners were announced at a virtual event this afternoon attended by...
Pregnant women’s expectations about postpartum sleep may predict sleep quality after birth, outweighing prior sleep and psychiatric history, a study suggests. The findings suggest attitudes and...
A weight loss jab may improve fertility outcomes in women with PMOS, early findings from an ongoing clinical trial suggest. The proof-of-concept analysis found that injectable...
Women’s Health Week Europe 2026 has opened applications for its flagship start-up Pitches, giving women’s health innovators the chance to present on the mainstage at The...
